SBIR/STTR Research Award

Standardization of HER-2/neu Tests

Award identifier 1c7dee27930b86f75947e3950d3fdc167b7c26166b7dcfbec7d43fa8af3f3367Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,995

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CELL CONTROL SCIENCES, LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (Applicant's abstract): Breast cancer is one of the greatest threats to the health and well being of every woman. The detection, diagnosis, and treatment of this cancer is a major initiative in the United States. HER-2/neu overexpression is associated with breast cancer prognosis and response to chemotherapy or endocrine therapy. Her-2/neu overexpression/amplification can be assessed by different techniques, including immunohistochemistry, fluorescence in situ hybridization (FISH), and various genetic hybridizations. However, the assessment of this important prognostic maker is hampered by the lack of standardization of the various methodologies, scoring systems, and widely accepted controls. Moreover, there is no general data bank where the laboratories can post their results for either comparison with other laboratories or evaluation of self-performance. We suggest that, if uniform, cell culture-based control slides were used by individual laboratories, this would ensure proper quality control over time and allow correlation of results with other laboratories. Potentially such controls could be used as standards and calibrators for quantitative immunohistochemistry, fluorescence in situ hybridization, and various genetic hybridization procedures. The specific aims of this proposal are : 1) To prepare cell culture-based controls for immunohistochemical detection of Her-2/neu protein; 2) To prepare cell culture-based controls for fluorescence in situ hybridization (FISH) analysis of the Her-2/neu oncogene; 3) To prepare cell culture-based controls for polymerase chain reaction (PCR), Southern blots, Northern blots, and Western blot hybridization analysis of the Her-2/neu oncogene. PROPOSED COMMERCIAL APPLICATIONS: Uniform and replenishable control slides prepared from cultured cells can be marketed as standards and calibrators for quantitative immunohistochemistry, fluorescence in situ hybridization, and various genetic hybridizations in diagnostic laboratories around the world. These controls ensure proper quality control over time and to allow correlation of results among multiple laboratories.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.